About the Authors

Nicolas Deblon

Affiliation Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Christelle Veyrat-Durebex

Affiliation Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Lucie Bourgoin

Affiliation Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Aurélie Caillon

Affiliation Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Anne-Lise Bussier

Affiliation Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Stefania Petrosino

Affiliation Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Naples, Italy

Fabiana Piscitelli

Affiliation Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Naples, Italy

Jean-Jacques Legros

Affiliation Centre Hospitalier Régional de la Citadelle, University of Liege, Liege, Belgium

Vincent Geenen

Affiliation Centre of Immunology, University of Liege, CHU B-23, Liege, Belgium

Michelangelo Foti

Affiliation Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Walter Wahli

Affiliation Center for Integrative Genomics, National Research Center Frontiers in Genetics, University of Lausanne, Lausanne, Switzerland

Vincenzo Di Marzo

Affiliation Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Naples, Italy

Françoise Rohner-Jeanrenaud

francoise.jeanrenaud@unige.ch

Affiliation Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Competing Interests

The authors have read the journal's policy and have the following conflicts: Patent application N° PCT/IB2011/052156 covering novel therapeutic uses of oxytocin has been filed on 17 May 2011. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: ND FRJ. Performed the experiments: ND FRJ CVD LB MF AC ALB SP VDM FP. Analyzed the data: ND. Contributed reagents/materials/analysis tools: JJL WW VG. Wrote the paper: ND FRJ.